Literature DB >> 15920760

Loss of shear stress induces leukocyte-mediated cytokine release and blood-brain barrier failure in dynamic in vitro blood-brain barrier model.

Ljiljana Krizanac-Bengez1, Marc R Mayberg, Edwin Cunningham, Mohammed Hossain, Stephen Ponnampalam, Fiona E Parkinson, Damir Janigro.   

Abstract

Brain ischemia is associated with an acute release of pro-inflammatory cytokines, notably TNF-alpha and IL-6 and failure of the blood-brain barrier. Shear stress, hypoxia-hypoglycemia, and blood leukocytes play a significant role in blood-brain barrier failure during transient or permanent ischemia. However, these mechanisms have not been studied as independent variables for in vitro ischemia. The present study, using a dynamic in vitro blood-brain barrier model, showed that flow cessation/reperfusion under normoxia-normoglycemia or hypoxia-hypoglycemia without blood leukocytes in the luminal perfusate had a modest, transient effect on cytokine release and blood-brain barrier permeability. By contrast, exposure to normoxic-normoglycemic flow cessation/reperfusion with blood leukocytes in the luminal perfusate led to a significant increase in TNF-alpha and IL-6, accompanied by biphasic blood-brain barrier opening. Enhanced permeability was partially prevented with an anti-TNF-alpha antibody. In leukocyte-free cartridges, the same levels of IL-6 had no effect, while TNF-alpha caused a moderate increase in blood-brain barrier permeability, suggesting that blood leukocytes are the prerequisite for cytokine release and blood-brain barrier failure during reduction or cessation of flow. These cells induce release of TNF-alpha early after ischemia/reperfusion; TNF-alpha triggers release of IL-6, since blockade of TNF-alpha prevents IL-6 release, whereas blockade of IL-6 induces TNF-alpha release. Pre-treatment of blood leukocytes with the cyclooxygenase (COX) inhibitor, ibuprofen, inhibited cytokine release and completely preserved blood-brain barrier permeability during the reperfusion period. In conclusion, loss of flow (flow cessation/reperfusion) independent of hypoxia-hypoglycemia plays a significant role in blood-brain barrier failure by stimulating leukocyte-mediated inflammatory mechanisms. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15920760     DOI: 10.1002/jcp.20429

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  25 in total

1.  A dynamic in vitro BBB model for the study of immune cell trafficking into the central nervous system.

Authors:  Luca Cucullo; Nicola Marchi; Mohammed Hossain; Damir Janigro
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-15       Impact factor: 6.200

Review 2.  Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models.

Authors:  Yukio Takeshita; Richard M Ransohoff
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 3.  Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure.

Authors:  Stephen F Rodrigues; D Neil Granger
Journal:  Cardiovasc Res       Date:  2010-03-17       Impact factor: 10.787

Review 4.  In vitro blood-brain barrier models: current and perspective technologies.

Authors:  Pooja Naik; Luca Cucullo
Journal:  J Pharm Sci       Date:  2011-12-27       Impact factor: 3.534

Review 5.  Cell-culture models of the blood-brain barrier.

Authors:  Yarong He; Yao Yao; Stella E Tsirka; Yu Cao
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

Review 6.  Fetal inflammatory response and brain injury in the preterm newborn.

Authors:  Shadi Malaeb; Olaf Dammann
Journal:  J Child Neurol       Date:  2009-07-15       Impact factor: 1.987

Review 7.  In vitro cerebrovascular modeling in the 21st century: current and prospective technologies.

Authors:  Christopher A Palmiotti; Shikha Prasad; Pooja Naik; Kaisar M D Abul; Ravi K Sajja; Anilkumar H Achyuta; Luca Cucullo
Journal:  Pharm Res       Date:  2014-08-07       Impact factor: 4.200

8.  Tobacco smoke: a critical etiological factor for vascular impairment at the blood-brain barrier.

Authors:  M Hossain; T Sathe; V Fazio; P Mazzone; Babette Weksler; D Janigro; E Rapp; L Cucullo
Journal:  Brain Res       Date:  2009-06-17       Impact factor: 3.252

Review 9.  Fluid shear stress-induced osteoarthritis: roles of cyclooxygenase-2 and its metabolic products in inducing the expression of proinflammatory cytokines and matrix metalloproteinases.

Authors:  Pu Wang; Pei-Pei Guan; Chuang Guo; Fei Zhu; Konstantinos Konstantopoulos; Zhan-You Wang
Journal:  FASEB J       Date:  2013-08-20       Impact factor: 5.191

10.  Combined effects of prenatal inhibition of vasculogenesis and neurogenesis on rat brain development.

Authors:  Q Y Fan; S Ramakrishna; N Marchi; Vincent Fazio; Kerri Hallene; D Janigro
Journal:  Neurobiol Dis       Date:  2008-09-30       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.